17-06-2026 17:35 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  About Us   Services             Trading   Depository    
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Board Meetings
Mankind Pharma Ltd.
 
Source DateBoard Meeting DateDetails
07-May-2026 19-May-2026 Audited Results & Quarterly Results
09-Jan-2026 03-Feb-2026 Quarterly Results
27-Oct-2025 06-Nov-2025 Quarterly Results
14-Jul-2025 31-Jul-2025 Quarterly Results & Interim Dividend
08-May-2025 21-May-2025 Audited Results
13-Jan-2025 23-Jan-2025 Quarterly Results
25-Oct-2024 05-Nov-2024 Quarterly Results
17-Sep-2024 20-Sep-2024 Raising of Funds Inter alia, to consider and approve the raising of funds by way of issue of non-convertible debentures, commercial papers, other debt securities or any other security or any combination thereof for an amount as may be decided by the Board.
18-Jul-2024 31-Jul-2024 Quarterly Results
08-May-2024 15-May-2024 Audited Results Inter alia, to evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals.
16-Jan-2024 31-Jan-2024 Quarterly Results
11-Oct-2023 31-Oct-2023 Quarterly Results
18-Jul-2023 02-Aug-2023 Quarterly Results
23-May-2023 30-May-2023 Quarterly Results & Audited Results
Page 1 of 1
Prev || Next
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Few Important Links: NSE | BSE | NSDL | CDSL | SEBI | MCX | NCDEX | FMC | RBI | AMFI | My Company GST Number | SCORES | DP 15 | BSE PLUS
Contact Us | Careers | Downloads | Notice |Margin Obligation Circular |Creating Investor | Policies| Details of KMPS | Public information for Investors
Circular | BOI UPI ID & QR Code
SEBI Reg. No INZ000209538 Depository CDSL: IN-DP-15-2015 Research Reg. No.: INH000011219
© 2006 J G Shah Financial Consultants Pvt.Ltd. All rights reserved.
Designed || Developed & Content Powerd By Accord Fintech Pvt. Ltd.